secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2024-12-06T23:59:59+00:00
Accession:  0001437749-24-036862
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences CEO Barrett resigns; Danahy, Uecker named interim executives
------------------------------------------------------------------------------

- CEO Burke T. Barrett resigns effective Dec 6, 2024; also leaves board Dec 2, 2024.
- Resignation not due to any disagreement; company affirms development and clinical plans on track.
- Severance: 12 months base salary (24 installments), $106,009.61 bonus, partial vesting of 101,000 options at $7.45, COBRA.
- Chief Commercial Officer Kevin Danahy and CTO Darrin Uecker serve as interim principal executive and financial officers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774924036862/0001437749-24-036862-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774924036862/plse20241206c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-036862

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer